What We Do: Drug Policy Research
Established in 2008, the Ontario Drug Policy Research Network (ODPRN) is a collaboration between researchers and drug policy decision-makers across Ontario with the goal of responding rapidly to policymakers’ needs to provide timely, relevant and scientifically rigorous research. The ODPRN is a global leader in integrating evidence into policy-making to impact societal outcomes and improve healthcare system efficiency.
Learn More
Effect of listing strategies on utilization of antitumor necrosis factor biologics infliximab and etanercept: a cross-sectional analysis from Ontario, Canada
Dental opioid prescription characteristics and the risk of new, persistent use
Prescription opioid characteristics at initiation for non-cancer pain and risk of treated opioid use disorder: A population-based study 
Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada
Understanding prescribing trends for hepatitis C treatment in Ontario
Opioid-related deaths in Ontario up among younger men during pandemic, report says
More drug shortages are inevitable unless we act now
Ontario family doctors warn early supply drying up as they see surge in demand for flu shot